Cargando…

Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting

The literature demonstrates that the quality of cancer family history (CFH) as currently collected in the outpatient setting is inadequate to assess disease risk. Prior to implementation of a web-based application for cancer family history collection, we aimed to review the quality of collected CFH...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jenny, Wolfe, Isabel, Ahsan, Muhammad Danyal, Krinsky, Hannah, Lackner, Andreas I., Pelt, Joe, Bolouvi, Karen, Gamble, Charlotte, Thomas, Charlene, Christos, Paul J., Cantillo, Evelyn, Holcomb, Kevin, Chapman-Davis, Eloise, Sharaf, Ravi, Lipkin, Steven M., Blank, Stephanie V., Frey, Melissa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861387/
https://www.ncbi.nlm.nih.gov/pubmed/35242980
http://dx.doi.org/10.1016/j.gore.2022.100941
Descripción
Sumario:The literature demonstrates that the quality of cancer family history (CFH) as currently collected in the outpatient setting is inadequate to assess disease risk. Prior to implementation of a web-based application for cancer family history collection, we aimed to review the quality of collected CFH in a gynecologic oncology outpatient clinic and determine contributing patient factors. Medical records were reviewed for 200 new patients presenting between 4/2019–7/2019. CFH was collected during the patient interview and evaluated for inclusion of eight elements based on standards set by the genetics community. Univariate and multivariable linear regression analyses were utilized to evaluate the effect of patient characteristics on the number of relatives included in the CFH. Among our cohort of 200 patients, CFH was documented for 185 patients (92.5%). On univariate analysis, patients with a family history of cancer and prior genetic testing had significantly greater median number of relatives included in the CFH. On multivariable analysis, patients with family members with cancer had significantly more relatives included. Our data are consistent with the literature, suggesting that the current collection methods may not adequately capture all measures of a high quality CFH. Patients reporting no family history of cancer and those without prior genetic testing were least likely to have CFH that included key quality elements and these patients might benefit from health information technology CFH collection tools.